Sean Duffy has already raised hundreds of millions of dollars for his enterprise health company that is blending technology, behavior science, and medicine together.
On the Dealmakers Show Duffy talked about providing virtual care, innovating in the rigid and highly regulated US healthcare system, making sales at the enterprise level, managing boards, and leadership.
Read More: https://alejandrocremades.com/this-entrepreneur-raised-over-450-million-to-deliver-virtual-chronic-care-solutions/
A less invasive procedure to reduce the risk of stroke by clearing blockages of the carotid artery in the neck is being offered more widely as a result of recent approval by the Food & Drug Administration.
We are excited to offer our patients the Vivistim® System to magnify their potential to recover further.
One of the most frustrating things for our patients who had a stroke is the inability to perform activities of daily living because of the weakness of the upper limb.
Via; Hinge Health
We’re thrilled to announce that Hinge Health has been recognized in Employee Benefit News's 2022 Excellence in Benefits Awards! It's a reflection of Karen Stander, FACHE, Inessa Lurye, and the whole women’s pelvic health team's tireless work over the past year to help address the benefits gap that many women face when it comes to pelvic floor disorders. We’re proud to be a part of the conversation that advances the narrative around a condition that one in four women are silently suffering from: https://lnkd.in/dQHnYaFr
Dr. Peter Warnke and his team successfully completed the first vagus nerve stimulation implantation procedure in the Midwest
Via: Micro Transponder
This week neurosurgeon Dr. Peter Warnke and his team [at UChicago Medicine] successfully completed the first vagus nerve stimulation implantation procedure in the Midwest. Paired with rehabilitation this implant can help patients who have suffered from a stroke regain hand and arm movements.
Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients
Via: Monteris Medical
The randomized controlled multicenter study is the first-of-its kind to investigate LITT benefits in radiographically recurrent brain metastasis patients
Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study Evaluating TCAR® System in the Treatment of Standard Surgical Risk Patients
Via: Yahoo Finance
Read More: https://finance.yahoo.com/news/silk-road-medical-announces-first-201500112.html
Via: Medpage Today
Amazon recently sent shock waves through healthcare when they announced their $3.9 billion acquisitionopens in a new tab or window of One Medical. This follows its 2018 acquisition of PillPack and 2019 Amazon Care launch. With $29 billion of venture investmentopens in a new tab or window into digital health in 2021, this may seem like just another headline -- but we feel this one is different.
Via; Outset Medical
Yesterday, in groundbreaking #kidneycare news, the American Heart Association issued a statement in support of home dialysis over in-center dialysis for patients with kidney and cardiovascular disease, citing cardiovascular co-morbidities and poor outcomes from thrice-weekly in-center hemodialysis, which is currently the most common therapy performed worldwide.
Via: Outset Medical
January Mendoza, BSN, RN, the Regional Director of Acute Dialysis at St. Francis Medical Center (SFMC) led a monumental transition when her hospital became the first in California to use a novel hemodialysis technology: #TabloDialysis.